Literature DB >> 25709126

Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bank.

A O Shittu1, H O Olawumi1, J O Adewuyi1.   

Abstract

OBJECTIVE: To determine whether or not pre-donation testing of blood donors affords substantial cost savings without compromise to blood transfusion safety. Pre-donation testing of blood donors for Transfusion Transmissible Infections (TTIs) is done in most developing countries because substantial cost savings are made from resources, materials and man-hours which would have been spent to procure infected blood units. Simple rapid test kits used in pre-donation testing is not as sensitive as the Enzyme Linked Immuno-sorbent Assay (ELISA) method used in post-donation screening in a quality assured manner.
DESIGN: It is a retrospective study where records of pre- and post-donation tests done in donor clinic of University of Ilorin Teaching Hospital, between January and December 2010 were retrieved. All processes and inputs were evaluated and costs calculated for pre-donation testing by simple rapid techniques and post donation screening by ELISA.
RESULTS: 5000 prospective donors were tested in the study period. The cost of single rapid Pre-donation testing was less than that of single ELISA Post-donation screen. The cost of double rapid Pre-donation and Post donation ELISA screen exceeded the cost of single post donation ELISA screen. Substantial cost savings were made when single rapid Pre-donation testing is relied on. More blood units were found reactive for the TTIs with the more expensive Post-donation ELISA.
CONCLUSION: Pre-donation testing of blood donors was not cost effective. Although, there is an apparent savings if pre-donation testing is not followed by post-donation ELISA testing, it is done at a compromise to blood transfusion safety.

Entities:  

Keywords:  TTIs screening; post-donation; pre-donation

Mesh:

Year:  2014        PMID: 25709126      PMCID: PMC4335446          DOI: 10.4314/gmj.v48i3.7

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  5 in total

1.  Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.

Authors:  C R Seed; P Kiely; A J Keller
Journal:  Intern Med J       Date:  2005-10       Impact factor: 2.048

Review 2.  The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.

Authors:  S Kleinman; M P Busch; J J Korelitz; G B Schreiber
Journal:  Transfus Med Rev       Date:  1997-07

3.  Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.

Authors:  Shirley Owusu-Ofori; Jillian Temple; Francis Sarkodie; Margaret Anokwa; Daniel Candotti; Jean-Pierre Allain
Journal:  Transfusion       Date:  2005-02       Impact factor: 3.157

4.  Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa.

Authors:  Sanaullah Khan; Sobia Attaullah; Sultan Ayaz; Shahid Niaz Khan; Sumaira Shams; Ijaz Ali; Muhammad Bilal; Sami Siraj
Journal:  Virol J       Date:  2011-03-08       Impact factor: 4.099

5.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

  5 in total
  2 in total

1.  New infections and HIV-1 subtypes among febrile persons and blood donors in Oyo State, Nigeria.

Authors:  Babatunde A Olusola; David O Olaleye; Georgina N Odaibo
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 20.693

2.  Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.

Authors:  Alastair Heffernan; Ella Barber; Nicola A Cook; Asmaa I Gomaa; Yolande X Harley; Christopher R Jones; Aaron G Lim; Zameer Mohamed; Shevanthi Nayagam; Gibril Ndow; Rajiv Shah; Mark W Sonderup; C Wendy Spearman; Imam Waked; Robert J Wilkinson; Simon D Taylor-Robinson
Journal:  Open Forum Infect Dis       Date:  2017-11-17       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.